0001209191-18-020389.txt : 20180316
0001209191-18-020389.hdr.sgml : 20180316
20180316185423
ACCESSION NUMBER: 0001209191-18-020389
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180314
FILED AS OF DATE: 20180316
DATE AS OF CHANGE: 20180316
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Popovits Kimberly J
CENTRAL INDEX KEY: 0001333482
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51541
FILM NUMBER: 18697048
MAIL ADDRESS:
STREET 1: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GENOMIC HEALTH INC
CENTRAL INDEX KEY: 0001131324
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 770552594
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-556-9300
MAIL ADDRESS:
STREET 1: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-03-14
0
0001131324
GENOMIC HEALTH INC
GHDX
0001333482
Popovits Kimberly J
301 PENOBSCOT DR.
REDWOOD CITY
CA
94063
1
1
0
0
President and CEO
Common Stock
2018-03-09
5
G
0
E
1155
0.00
D
236157
I
Held by the Popovits 2010 Trust
Common Stock
2018-03-14
4
M
0
5000
17.18
A
241157
I
Held by the Popovits 2010 Trust
Common Stock
2018-03-14
4
S
0
5000
32.0096
D
236157
I
Held by the Popovits 2010 Trust
Common Stock
59617
D
Common Stock
12298
I
Held by Morgan Stanley as Custodian for Benefit of Kimberly Popovits
Common Stock
16825
I
Held in trust for the benefit of Ms. Popovits' son, of which Ms. Popovits is trustee.
Employee Stock Option (right to buy)
17.18
2018-03-14
4
M
0
5000
0.00
D
2020-02-18
Common Stock
0
92900
D
These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on June 6, 2017.
Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
Represents weighted average sale price. Actual sale prices ranged from $31.80 to $32.40.
Includes an aggregate of 51,204 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
The option became exercisable as to 25% of the shares on February 18, 2011, and became exercisable as to 1/48th of the shares each full month thereafter.
/s/ Jason W. Radford, Attorney-in-fact
2018-03-16